Skip to main content

Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

JP Morgan Lowers PT On CVS Caremark To $42
Joe Young  
 
February 04, 2011 7:11am   Comments
Share:

JP Morgan has lowered the price target on CVS Caremark Corporation (NYSE: CVS) from $45 to $42 and maintains its Overweight rating.

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

 

Related Articles (CVS)

Benzinga Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare — And Trade Deal Optimism Boosts Markets
Centene, Cigna, Others Drop As Molina's Results Rattle Sector
Assessing CVS Health: Insights From 8 Financial Analysts
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Is CVS Health Gaining or Losing Market Support?
Options Corner: Bullish Traders Eye Eli Lilly As Market Signals Hint At A Turnaround
View Comments and Join the Discussion!

Posted-In: CVS Caremark Corporation JP MorganPrice Target Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com